Received: 7 November 2022
Accepted: 15 March 2023
First Online: 29 March 2023
: Ethics approval has been provided by the ethics committee of First Affiliated Hospital of Chongqing Medical University, Chongqing, China (approval number: 2015ZY102, approval date:26/07/2021). Letters of informed consent signed by patients were obtained. This study was conducted in accordance with the principles of the Declaration of Helsinki. The trial was registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2100052214, registration date: 22/10/2021).
: Not applicable.
: The authors declare that they have no competing interests.